BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30744470)

  • 21. Eps8 expression is significantly lower in p16
    Nasri E; Wiesen LB; Knapik JA; Fredenburg KM
    Hum Pathol; 2018 Feb; 72():45-51. PubMed ID: 29107665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.
    de Carvalho AC; Scapulatempo-Neto C; Maia DC; Evangelista AF; Morini MA; Carvalho AL; Vettore AL
    BMC Med; 2015 May; 13():108. PubMed ID: 25956054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune response in cervical lymph nodes from patients with primary oral squamous cell carcinoma.
    Gonçalves AS; Costa NL; Arantes DA; de Cássia Gonçalves Alencar R; Silva TA; Batista AC
    J Oral Pathol Med; 2013 Aug; 42(7):535-40. PubMed ID: 23278174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible functions of CD169-positive sinus macrophages in lymph nodes in anti-tumor immune responses.
    Komohara Y; Ohnishi K; Takeya M
    Cancer Sci; 2017 Mar; 108(3):290-295. PubMed ID: 28002629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus in metastatic lymph nodes from unknown primary head and neck squamous cell carcinoma.
    Compton AM; Moore-Medlin T; Herman-Ferdinandez L; Clark C; Caldito GC; Wang XI; Thomas J; Abreo FW; Nathan CO
    Otolaryngol Head Neck Surg; 2011 Jul; 145(1):51-7. PubMed ID: 21493313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
    O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
    Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
    Lai K; Matthews S; Wilmott JS; Killingsworth MC; Yong JL; Caixeiro NJ; Wykes J; Samakeh A; Forstner D; Lee M; McGuinness J; Niles N; Hong A; Ebrahimi A; Lee CS
    BMC Cancer; 2018 Jun; 18(1):624. PubMed ID: 29859041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
    Troost EG; Vogel WV; Merkx MA; Slootweg PJ; Marres HA; Peeters WJ; Bussink J; van der Kogel AJ; Oyen WJ; Kaanders JH
    J Nucl Med; 2007 May; 48(5):726-35. PubMed ID: 17475960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus type 16 oropharyngeal cancers in lymph nodes as a marker of metastases.
    Mirghani H; Moreau F; Lefèvre M; Tam C; Périé S; Soussan P; St Guily JL
    Arch Otolaryngol Head Neck Surg; 2011 Sep; 137(9):910-4. PubMed ID: 21930979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relevance of the lymph node ratio as predictor of prognosis is higher in HPV-negative than in HPV-positive oropharyngeal squamous cell carcinoma.
    Meyer MF; Meinrath J; Seehawer J; Lechner A; Odenthal M; Quaas A; Semrau R; Huebbers CU; Marnitz S; Büttner R; Beutner D
    Clin Otolaryngol; 2018 Feb; 43(1):192-198. PubMed ID: 28714274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathological risk factors stratification in pN3b oral cavity squamous cell carcinoma: Focus on the number of positive nodes and extranodal extension.
    Liao CT; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Ng SH; Lin CH; Tsao CK; Kang CJ; Fang TJ; Huang SF; Chang KP; Yang LY; Yen TC
    Oral Oncol; 2018 Nov; 86():188-194. PubMed ID: 30409299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Performance of Adaptive 4D Volume Perfusion CT for Detecting Metastatic Cervical Lymph Nodes in Head and Neck Squamous Cell Carcinoma.
    Matoba M; Tsuji H; Shimode Y; Nagata H; Tonami H
    AJR Am J Roentgenol; 2018 Nov; 211(5):1106-1111. PubMed ID: 30240295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
    Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y
    Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma.
    Vasan K; Low TH; Gupta R; Ashford B; Asher R; Gao K; Ch'ng S; Palme CE; Clark JR
    Head Neck; 2018 May; 40(5):993-999. PubMed ID: 29360276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Origin of cystic squamous cell carcinoma metastases in head and neck lymph nodes: Addition of EBV testing improves diagnostic accuracy.
    Švajdler M; Kašpírková J; Hadravský L; Laco J; Dubinský P; Straka Ľ; Ondič O; Michal M; Skálová A
    Pathol Res Pract; 2016 Jun; 212(6):524-31. PubMed ID: 27013059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice.
    Veness MJ; Morgan GJ; Palme CE; Gebski V
    Laryngoscope; 2005 May; 115(5):870-5. PubMed ID: 15867656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary.
    Rollo F; Dona' MG; Pellini R; Pichi B; Marandino F; Covello R; Benevolo M
    Cytopathology; 2018 Oct; 29(5):449-454. PubMed ID: 29873841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD169 identifies an anti-tumour macrophage subpopulation in human hepatocellular carcinoma.
    Zhang Y; Li JQ; Jiang ZZ; Li L; Wu Y; Zheng L
    J Pathol; 2016 Jun; 239(2):231-41. PubMed ID: 27174787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma.
    van Dinther D; Veninga H; Revet M; Hoogterp L; Olesek K; Grabowska J; Borg EGF; Kalay H; van Kooyk Y; den Haan JMM
    Front Immunol; 2018; 9():1997. PubMed ID: 30237798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
    O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
    Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.